Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
T. Schneider, H. Hoffmann, H. Dienemann, A. E. Enk, K. Mahnke (Heidelberg, Germany). Proof of an immunosuppressive phenotype of dendritic cells in lung cancer microenvironment. Eur Respir J 2010; 36: Suppl. 54, 381

Member's Comments

No comment yet.

Related content which might interest you: Cytokine network in relation to regulatory cells in lung cancer microenvironment Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis in resected non–small cell lung cancer Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses tumor-specific T cell immunity Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 The role of resident lung mesenchymal stromal cells in normal and aberrant lung development Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020 The ability of autologous dendritic cells to destroy NSCLC cells in vitro Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 Anti-tumour effects of coculture of dendritic cells with cytokine-induced killer cells against lung cancer in vitro and in vivo Source: Eur Respir J 2006; 28: Suppl. 50, 387s Year: 2006 T-regulatory cells in COPD or tumour environment Source: Eur Respir J 2009; 34: 284 Year: 2009 Angiogenic T cells in interstitial lung diseases Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 Fibrosis-specific stem-like cells in peripheral IPF lung: Characteristics and potential role Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 High CO2 tumor microenvironment confers chemoresistance in lung cancer cells. Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 Immunosuppressive properties of bronchial epithelial cells are altered in lung transplant recipients: “ex-vivo” model of T cell-allogeneic response Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013 Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival Source: Eur Respir J 2009; 33: 118-126 Year: 2009 Intersections of lung progenitor cells, lung disease and lung cancer Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017 Year: 2017 Influence mesenchymal stem cells on aneuploidy of the tumor cells of Lewis lung carcinoma Source: International Congress 2019 – Biology of lung cancer Year: 2019 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Circulating CD133(+) stem cells in lung cancer patients Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Exploration of the evidence of cancer stem cells in lung cancer Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009